Chloramphenicol/Colistimethate sodium

氯霉素/多黏菌素E甲磺酸钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChloramphenicol/Colistimethate sodium
Drug Alias Name氯霉素-多黏菌素E甲磺酸钠Chloramphenicol+Colistimethate sodiumChloramphenicol-Colistimethate sodium氯霉素和多黏菌素E甲磺酸钠Chloramphenicol/Colistin Sodium Methanesulfonate +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBlepharitisKeratitisConjunctivitis
Global Approved IndicationsBlepharitisKeratitisConjunctivitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1975/06/12
Country/TerritoryJapan
CombinationsYes ChloramphenicolColistimethate sodium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWakamoto
China Registration ClassN/A

Develop Information

Active CompaniesWakamoto
Inactive CompaniesN/A
Active IndicationsBlepharitisKeratitisConjunctivitis
Inactive IndicationsN/A

Other Information

ATC CodeS01AX
Related LinksKEGG